Home Metis Precision Medicine

Metis Precision Medicine

Metis Precision Medicine

Metis Precision Medicine
Category
Business Description
Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action. Currently seeking investors, biotech, or pharmaceutical companies interested in acquiring the relevant platform technology on a global basis.
Based in
Turin
Tags
Biotechnology, Health Care, Pharmaceutical
Total Funding
Between €1 million-€ 2.5 million
Founded
2017
Website
https://www.metisprecisionmedicine.org/
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Metis Precision Medicine? We're happy to assist you with our Startup Sourcing service.